Grupo farmacéutico · Suiza
Roche
Un grupo de 34 empresas con 1000 medicamentos en 11 países.
Estructura del grupo
34 empresas en 20 países
Grupo farmacéutico · Suiza
Un grupo de 34 empresas con 1000 medicamentos en 11 países.
34 empresas en 20 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 1000
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| ACCUTANE10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Isotretinoin | Estados Unidos | No comercializado | 1982 |
| ACTEMRA162 mg / 0.9 ml · Solution | Tocilizumab | Canadá | Comercializado | 2019 |
| Actemra162mg/0.9ml · Injection | Tocilizumab | Estados Unidos | Comercializado | 2018 |
| ACTEMRA200 mg / 10 ml · Solution | Tocilizumab | Canadá | Comercializado | 2010 |
| ACTEMRA162 mg / 0.9 ml · Solution | Tocilizumab | Canadá | Comercializado | 2014 |
| ACTEMRA80 mg / 4 ml · Solution | Tocilizumab | Canadá | Comercializado | 2010 |
| ACTEMRA200mg/10ml | 400mg/20ml | 80mg/4ml · Injectable | Tocilizumab | Estados Unidos | Comercializado | 2010 |
| ACTEMRA400 mg / 20 ml · Solution | Tocilizumab | Canadá | Comercializado | 2010 |
| ACTEMRA162mg/0.9ml · Injectable | Tocilizumab | Estados Unidos | Comercializado | 2013 |
| Actemra 162mg Solution for Injection in Pre-filled Syringe 162mg/0.9ml162 mg/0.9 mL · Injection, solution | Tocilizumab | Singapur | Autorizado | 2015 |
| Actemra Concentrate for Solution for Infusion 20mg/ml20mg/ml · Infusion, solution concentrate | Tocilizumab | Singapur | Autorizado | 2009 |
| Actemra®80mg/4mL · koncentrat za rastvor za infuziju | Tocilizumab | Serbia | Autorizado | 2025 |
| Actemra®200mg/10mL · koncentrat za rastvor za infuziju | Tocilizumab | Serbia | Autorizado | 2025 |
| Actemra®162mg · rastvor za injekciju u napunjenom injekcionom špricu | Tocilizumab | Serbia | Autorizado | 2025 |
| Actemra®400mg/20mL · koncentrat za rastvor za infuziju | Tocilizumab | Serbia | Autorizado | 2025 |
| ACTIVASE100mg/vial | 50mg/vial · Vial | Alteplase | Estados Unidos | Comercializado | 1987 |
| ACTIVASE RT-PA100 mg / kit + 100 ml / kit · Liquid, Powder For Solution | Alteplase, Water | Canadá | Comercializado | 1996 |
| ACTIVASE RT-PA50 mg / kit + 50 ml / kit · Liquid, Powder For Solution | Alteplase, Water | Canadá | Comercializado | 1998 |
| AEROBID0.25mg/inh · Aerosol, metered | Flunisolide | Estados Unidos | No comercializado | 1984 |
| ALECENSACapsula rigida | Alectinib | Italia | Autorizado | |
| ALECENSA150mg base · Capsule | Alectinib | Estados Unidos | Comercializado | 2015 |
| Alecensa | Alectinib | UE (EMA) | Autorizado | 2017 |
| ALECENSA 150 MG CAPSULAS DURAS161,33 mg · Cápsula dura | Alectinib | España | Comercializado | 2025 |
| ALECENSA 150 MG CAPSULAS DURAS161,33 mg · Cápsula dura | Alectinib | España | Autorizado | 2026 |
| ALECENSA 150 MG CAPSULAS DURAS161,33 mg · Cápsula dura | Alectinib | España | Comercializado | 2017 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Canadá | 238 | 82 | 156 | EmpresasTodos los medicamentos |
| Estados Unidos | 145 | 139 | 6 | EmpresasTodos los medicamentos |
| España | 144 | 126 | 18 | EmpresasTodos los medicamentos |
| Arabia Saudí | 132 | 132 | 0 | EmpresasTodos los medicamentos |
| Países Bajos | 90 | 90 | 0 | EmpresasTodos los medicamentos |
| Singapur | 61 | 61 | 0 | EmpresasTodos los medicamentos |
| Rumanía | 58 | 0 | 58 | EmpresasTodos los medicamentos |
| Serbia | 57 | 51 | 6 | EmpresasTodos los medicamentos |
| Unión Europea (EMA) | 40 | 30 | 10 | EmpresasTodos los medicamentos |
| Italia | 33 | 33 | 0 | EmpresasTodos los medicamentos |
| Croacia | 2 | 2 | 0 | EmpresasTodos los medicamentos |
También en los registros de Brasil, Francia, Reino Unido
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Source: European Medicines Agency (EPAR data).
Licencia: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licencia: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licencia: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; Crown copyright MHRA factual register
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licencia: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licencia: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
AIFA; Gazzetta Ufficiale della Repubblica Italiana. Exact act IDs, publication dates, locators, URLs and retrieval dates. Normalized by Prognia; no official endorsement.
Licencia: Official administrative act text exclusion, Italian Law633/1941 Article5
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licencia: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licencia: Italian Open Data Licence
State Enterprise Centre of Registers / Valstybės įmonė Registrų centras; source dataset/resource URL, exact original code/UUID/revision, original CSV ordinal, retrieval time; CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ ; selected field normalization by Prognia.
Licencia: Creative Commons Attribution
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licencia: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licencia: Norwegian Licence for Open Government Data
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
Oficiul Național al Registrului Comerțului; exact original source URLs, snapshot2026-09-02 where applicable, retrieval date, original record locators; https://creativecommons.org/licenses/by/4.0/
Licencia: Creative Commons Attribution
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licencia: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licencia: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licencia: Singapore Open Data Licence
Register právnických osôb, podnikateľov a orgánov verejnej moci; public API licence names Štatistický úrad Slovenskej republiky; administration transferred to Ministerstvo vnútra SR; original API URL, literal identifier and source locators, source version and retrieval date; https://creativecommons.org/licenses/by/4.0/; normalization identified.
Licencia: Creative Commons Attribution
Slovak Ministry of Finance, Register účtovných závierok (RÚZ) Open API; exact IČO/accounting-unit, filing, report and template IDs; original API URLs, source locators and retrieval dates; https://www.registeruz.sk/cruz-public/home/api; extraction/normalization stated.
Licencia: CC0
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licencia: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Roche en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaGrupos farmacéuticos conocidos, cada uno con todas sus empresas.
Ordenados por su número de medicamentos.